Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Gut microbes

• Publication date

  2017-01-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/19490976.2017.1286006PMID 28129018PMCID PMC5479407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• For Rapid Molecular Detection, Why Not a Whole Genome Approach?

  2016cited by this paper
• Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy

  2016cited by this paper
• Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.

  2016cited by this paper
• Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

  2016cited by this paper
• Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort

  2016cited by this paper
• Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota

  2016cited by this paper
• Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection

  2016cited by this paper
• Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.

  2016cited by this paper
• Healthy human gut phageome

  2016cited by this paper
• Fecal Transplantation for Clostridium Difficile—“All Stool May Not Be Created Equal”

  2016cited by this paper
• Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

  2016influential reference
• Active Surveillance and Isolation of Asymptomatic Carriers of Clostridium difficile at Hospital Admission: Containing What Lies Under the Waterline.

  2016cited by this paper
• Systematic Review: Adverse Events of Fecal Microbiota Transplantation

  2016influential reference
• Reply to Lesho and Clifford.

  2016cited by this paper
• Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

  2016cited by this paper
• The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

  2016cited by this paper
• Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

  2016cited by this paper
• Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.

  2016cited by this paper
• Weight Gain After Fecal Microbiota Transplantation

  2015cited by this paper
• Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

  2015cited by this paper
• Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers

  2015cited by this paper
• Fecal Microbiota Transplantation for Clostridium difficile Infection

  2015cited by this paper
• Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

  2015cited by this paper
• Low prevalence of Blastocystis sp. in active ulcerative colitis patients

  2015cited by this paper
• Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

  2015cited by this paper
• Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications

  2015cited by this paper
• Ensuring the safe and effective FDA regulation of fecal microbiota transplantation

  2015cited by this paper
• How Next-Generation Sequencing and Multiscale Data Analysis Will Transform Infectious Disease Management

  2015cited by this paper
• Disease-specific alterations in the enteric virome in inflammatory bowel disease.

  2015cited by this paper
• Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

  2015cited by this paper
• The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study.

  2015cited by this paper
• Burden of Clostridium difficile infection in the United States.

  2015cited by this paper
• Multicenter Evaluation of the BioFire FilmArray Gastrointestinal Panel for Etiologic Diagnosis of Infectious Gastroenteritis

  2015cited by this paper
• Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective?

  2015cited by this paper
• Donor Recruitment for Fecal Microbiota Transplantation

  2015cited by this paper
• Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

  2015cited by this paper
• The regulation of fecal microbiota for transplantation: An international perspective for policy and public health

  2015cited by this paper
• 499 Donor Recruitment and Eligibility for Fecal Microbiota Transplantation: Results From an International Public Stool Bank

  2015cited by this paper
• Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

  2015cited by this paper
• Fecal Microbiota Transplantation and Successful Resolution of Multidrug-Resistant-Organism Colonization

  2015cited by this paper
• Policy: How to regulate faecal transplants

  2014cited by this paper
• Blastocystis Is Associated with Decrease of Fecal Microbiota Protective Bacteria: Comparative Analysis between Patients with Irritable Bowel Syndrome and Control Subjects

  2014cited by this paper
• Fecal microbial therapy: promises and pitfalls.

  2014cited by this paper
• Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea

  2014cited by this paper
• Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1

  2014cited by this paper
• Microbes, microbiota, and colon cancer.

  2014cited by this paper
• Microbiota organization is a distinct feature of proximal colorectal cancers

  2014cited by this paper
• Comparison of brush and biopsy sampling methods of the ileal pouch for assessment of mucosa-associated microbiota of human subjects

  2014cited by this paper
• The Human Gut Microbiome as a Screening Tool for Colorectal Cancer

  2014cited by this paper
• The human mycobiome in health and disease

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection

  2013cited by this paper
• Rapid evolution of the human gut virome

  2013cited by this paper
• Burden of Clostridium difficile on the Healthcare System

  2012cited by this paper
• Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

  2012cited by this paper
• Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?

  2012cited by this paper
• Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI

  2012cited by this paper
• Treating Clostridium difficile infection with fecal microbiota transplantation.

  2011cited by this paper
• Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

  2011cited by this paper
• A review of the clinical presentation of dientamoebiasis.

  2010cited by this paper
• Viruses in the fecal microbiota of monozygotic twins and their mothers

  2010cited by this paper
• Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital

  2010cited by this paper
• Comparison of a Commercial Real-Time PCR Assay for tcdB Detection to a Cell Culture Cytotoxicity Assay and Toxigenic Culture for Direct Detection of Toxin-Producing Clostridium difficile in Clinical Samples

  2008cited by this paper
• Diversity of the Human Intestinal Microbial Flora

  2005cited by this paper
• American gastroenterological association

  2001cited by this paper
• Irregular shedding of Blastocystis hominis

  1999cited by this paper
• Diet and colon cancer.

  1979cited by this paper

• Harnessing the gut-heart axis for cardiovascular drug innovation: microbiome, metabolites, and personalized treatment strategies.

  2026cites this paper
• Evaluation of the antibacterial activity of the natural product α-mangostin against Clostridioides difficile

  2026cites this paper
• Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile.

  2026cites this paper
• Exploring Fecal Microbiota Transplantation: Potential Benefits, Associated Risks, and Challenges in Cancer Treatment

  2026cites this paper
• Gut dysbiosis and neurological diseases: A narrative review of the gut-brain axis

  2026cites this paper
• Bridging the gap in the management of Alzheimer's disease using fecal microbiota transplantation.

  2025cites this paper
• Personalised Bacteriophage-enriched Faecal Microbiota Transplantation: A Precision Microbiome Modulation Therapy for Helicobacter pylori Eradication

  2025cites this paper
• The antiarrhythmic drugs dronedarone and amiodarone exhibit potent in vitro and in vivo activity against Clostridioides difficile.

  2025cites this paper
• Microbiome dysbiosis and chemotherapy resistance in acute myeloid leukemia (AML)

  2025cites this paper
• Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring.

  2025cites this paper
• Characteristics and longitudinal stability of Gut Microbiota in healthy individuals across different age groups

  2025cites this paper
• Monitoring for Clostridioides difficile-associated infection in hospital

  2025cites this paper
• Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

  2025cites this paper
• Emerging concepts and shifting paradigms for understanding the microbial basis of inflammatory bowel diseases

  2025cites this paper
• Gut Microbiota in Psychiatric and Neurological Disorders: Current Insights and Therapeutic Implications

  2025cites this paper
• Gut Virus Axis: Unravelling Viral Contribution to Gut Microbiota Dysbiosis and Translational Medicine in Inflammatory Bowel Disease (IBD)

  2025cites this paper
• Microbiome Therapeutics for Clostridioides difficile Infection.

  2025cites this paper
• Unveiling the therapeutic potential of the gut microbiota–brain axis: Novel insights and clinical applications in neurological disorders

  2025cites this paper
• Effect of the Multi‐Strain Probiotic SYN‐53 in the Management of Allergic Rhinoconjunctivitis

  2025cites this paper
• The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases

  2025cites this paper
• New Insights into a Conceptual Bionic Colonic Bioreactor: A Model, ‘Probiotics in Human Colon’, Showing How Probiotics Alleviate Constipation from a Bioprocess Engineering Perspective

  2025cites this paper
• Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive Review

  2025cites this paper
• Fecal microbiota transplantation: present and future

  2025cites this paper
• Probiotic use reduces the incidence of antibiotic-associated diarrhea among adult patients: a meta-analysis

  2025cites this paper
• Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.

  2025cites this paper
• Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation.

  2024cites this paper
• Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus

  2024cites this paper
• Probiotics for Prevention and Treatment of Clostridium difficile Infection.

  2024cites this paper
• Progress in the Treatment of Pediatric Antibiotic-Associated Diarrhea with Traditional Chinese Medicine and Western Medicine

  2024cites this paper
• Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation

  2024cites this paper
• Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products

  2024cites this paper
• Gut Microbiome Wellness Index 2 enhances health status prediction from gut microbiome taxonomic profiles

  2024influential citation
• Clinical Guidelines for Fecal Microbiota Transplantation in Companion Animals

  2024cites this paper
• Fecal microbiota transplantation for the treatment of intestinal diseases after allogeneic hematopoietic stem cell transplantation in children

  2024cites this paper
• Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile

  2024cites this paper
• Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation

  2024cites this paper
• Recurrent Clostridioides difficile Infection and Outcome of Fecal Microbiota Transplantation Use: A Population-Based Assessment

  2024cites this paper
• Economic and Chronologic Optimization of Fecal Donors Screening Process

  2024cites this paper
• Microbes in Health and Disease: Human Gut Microbiota

  2024cites this paper
• Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond

  2024cites this paper
• Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details

  2024cites this paper
• Effects of gut microbiota on neurodegenerative diseases

  2023cites this paper
• Epigenetics and the role of nutraceuticals in health and disease

  2023cites this paper
• Utility of BioFire FilmArray Gastrointestinal Panel in the Diagnosis of Gastrointestinal Infections

  2023cites this paper
• Fecal Microbiota Transplantation in Liver Cirrhosis

  2023cites this paper
• Gut bacterial consortium enriched in a biofloc system protects shrimp against Vibrio parahaemolyticus infection

  2023cites this paper
• The long and winding road of faecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy

  2023cites this paper
• Procedure, Screening, and Cost of Fecal Microbiota Transplantation

  2023cites this paper
• Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application

  2022cites this paper
• The emerging potential of microbiome transplantation on human health interventions

  2022cites this paper
• The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications

  2022cites this paper
• Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery

  2022cites this paper
• Host gut resistome in Gulf War chronic multisymptom illness correlates with persistent inflammation

  2022cites this paper
• Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives

  2022cites this paper
• Fecal microbiota transplantation: a review on current formulations in Clostridioides difficile infection and future outlooks

  2022cites this paper
• Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application

  2022cites this paper
• The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer

  2022cites this paper
• Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China.

  2022cites this paper
• A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process

  2022cites this paper
• Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems

  2022cites this paper
• The gut microbiome in human health and disease—Where are we and where are we going? A bibliometric analysis

  2022cites this paper
• Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank

  2021cites this paper
• A Narrative Review of the Current Evidence of Fecal Microbiota Transplant as Curative Therapy for Recurrent Clostridioides difficile Infection

  2021influential citation
• Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test

  2021cites this paper
• Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

  2021cites this paper
• Gut resistome presents a unique biome signature in chronic multi-symptom illness patients and links persistent pro-inflammatory phenotype in a mouse model reversible by fecal microbiota transfer

  2021cites this paper
• Healthcare providers’ perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review

  2021cites this paper
• The gut microbiome and efficacy of cancer immunotherapy.

  2021cites this paper
• Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer’s Disease

  2021cites this paper
• Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases

  2021cites this paper
• Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT)

  2021cites this paper
• Host gut microbiome and potential therapeutics in gulf war illness: A short review.

  2021cites this paper
• Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients

  2021cites this paper
• Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control

  2021cites this paper
• A synthetic consortium of 100 gut commensals modulates the composition and function in a colon model of the microbiome of elderly subjects

  2021cites this paper
• Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy

  2021cites this paper
• What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis

  2021cites this paper
• Sequence Meets Function-Microbiota And Cardiovascular Disease.

  2021cites this paper
• Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond

  2020cites this paper
• Diarrhoea And Intestinal Microbiota

  2020cites this paper
• Manipulating the gut microbiota

  2020cites this paper
• Ultrapotent inhibitor of Clostridioides difficile growth, which suppresses recurrence in vivo.

  2020cites this paper
• A newly isolated E. thailandicus strain d5B with exclusively antimicrobial activity against C. difficile might be a novel therapy for controlling CDI.

  2020cites this paper
• One Health Probiotics plus Hot Topic : Australian COVID-19 vaccine

  2020cites this paper
• Secondary causes of inflammatory bowel diseases

  2020cites this paper
• Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease

  2020cites this paper
• Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor

  2020cites this paper
• Faecal microbiota transplantation: a review

  2020cites this paper
• Fecal microbiota transplantation for treatment of irritable bowel syndrome

  2020cites this paper
• Gut Microbiome in Obesity Management

  2020cites this paper
• A Recent Overview of Microbes and Microbiome Preservation

  2020cites this paper
• Improving Risk-Benefit in Faecal Transplantation through Microbiome Screening.

  2020cites this paper
• In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

  2019cites this paper
• Fecal Transplant: How an Ancient Therapy Is Finding a New Use in Today’s Antibiotic-Resistant Era

  2019cites this paper
• Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

  2019cites this paper
• Ethical implications of recruiting universal stool donors for faecal microbiota transplantation.

  2019cites this paper
• Evolving Strategies to Manage Clostridium difficile Colitis

  2019cites this paper
• Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients

  2019cites this paper
• Infections and the Rheumatic Diseases

  2019cites this paper
• Nutrition and the Gut Microbiome: General Recommendations for the Microbiota Enrichment Program Website

  2019cites this paper